By Business/Source
Currency:JPY
2025/FY
Stock NameRevenueRatio
Radioactive pharmaceutical business16.88B91.13%
Drug discovery and development business2.79B15.08%
Adjustment amount-1.15B-6.21%
By Country/Region
Currency:JPY
2025/FY
Stock NameRevenueRatio
Japan15.76B85.08%
United States1.68B9.09%
Europe763.08M4.12%
Others316.83M1.71%
